Philippines’ executive order on medicine price cap

Philippines’ President Rodrigo Duterte officially signed the executive order which would see a cap set on selected medicines at a maximum retail price.

Under Executive Order No. 104,

“Improving Access to Healthcare through the Regulation of Prices in the Retail of Drugs and Medicines”.

There will be a price regulation set at,

  1. Maximum Retail Price,
  2. Maximum Wholesale Price

On both on certain drugs and medicines.

This comes after an intended proposal of price regulation which involved over 120 drugs for diseases and health conditions.

Under this MDRP scheme, there will be an average price reduction of 56% from market prices.

Looking at importing into The Philippines

Importing into the Philippines is pretty a straight forward process.

Provided the guidelines provided by the Bureau of Customs are adhered to.

Goods entering the Philippines’ territories are either regulated, restricted or prohibited due to domestic reasons.

They are classified under the following 4 classes;

  • Free Importation and Exportation
  • Regulated Importation and Exportation
  • Restricted Importation and Exportation
  • Prohibited Importation and Exportation

Hardcopy of Single Administrative Document (SAD) signed  the declarant and customs broker must be submitted to the Formal Entry Division (FED) alongside,

  • Commercial Invoice.
  • Packing List.
  • Duly notarized Supplemental Declaration on Valuation.
  • Duly endorsed Bill of Landing or Airway Bill.
  • All documents that may be required by specific rules and regulations.

Goods declaration must be lodged within 15 days from the date of discharge of the last package from the vessel or aircraft.

Goods imported into the Philippines are subject to duty and taxes upon importation.

Importation would begin when vessel or aircraft enters Philippine’s territories with the intention to unload therein.


Philippines FDA has been officially listed ASEAN MRA for GMP

Philippines FDA has been officially listed under the ASEAN Mutual Recognition Arrangement(MRA) on Good Manufacturing Practices(GMP) for medicinal products. This comes after the 28th ASEAN Consultative Committee On Standards And Quality Pharmaceutical Product Working Group (ACCSQ-PPWG) meeting on 19th & 20th December 2019.

This would result in result in reduced duplication of inspections, cost reduction, facilitation of exports, enhanced market access, enhanced industry reputation, transparency in inspection standards and consistency of inspection, in addition to increasing confidence in the quality of medicines for consumers, reliability and quality of medicines, improved consumer safety and protection, better control of counterfeit medicines, and improved access to affordable quality medicines.

Philippines would be the 5th country to be listed under the ASEAN MRA on GMP for Medicinal Products.

For more details, please refer to Philippines FDA’s press release: